Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135772 · ClinicalTrials.gov registry record
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 100
- Enrollment target
NCT00135772 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 100 participants.
The verdict
NCT00135772 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Nicotine dependence is very common among individuals with schizophrenia and schizoaffective disorder. Cotinine is a chemical that is made by the body from nicotine. Measuring levels of nicotine and cotinine is an accurate way to determine how much cigarette smoke enters a person's body. The purpose of this study is to measure nicotine and cotinine levels in smokers with schizophrenia or schizoaffective disorder to determine if such individuals absorb more nicotine per cigarette than smokers without schizophrenia-related disorders.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-10 |
| Est. Completion | 2004-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00135772
The ClinicalTrials.gov registry entry for NCT00135772 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00135772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00135772 about?
NCT00135772 is a clinical study titled "Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2". Nicotine dependence is very common among individuals with schizophrenia and schizoaffective disorder. Cotinine is a chemical that is made by the body from nicotine. Measuring levels of nicotine and cotinine is an accurate way to determine how much cigarette smoke enters a person's body. The purpose ...
What is the current status of trial NCT00135772?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2003-10. Estimated completion is 2004-07.
Who is sponsoring clinical trial NCT00135772?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.